Rezolute, Inc. (RZLT)
3.30
+0.10
(+3.12%)
USD |
NASDAQ |
May 01, 16:00
3.32
+0.02
(+0.61%)
After-Hours: 20:00
Rezolute EPS Diluted (Quarterly) : -0.2196 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| XOMA Royalty Corp. | 0.2586 |
| Ligand Pharmaceuticals, Inc. | 2.119 |
| ADMA Biologics, Inc. | 0.2025 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.77M |
| Total Expenses (Quarterly) | 22.77M |
| Enterprise Value | 184.15M |
| Earnings Yield | -27.99% |
| Normalized Earnings Yield | -27.99 |